---
layout: minimal-medicine
nav_exclude: true
title: Olaparib
---

# Olaparib

**Generic Name:** Olaparib

**Usage:** Olaparib is a type of cancer medication called a PARP inhibitor.  It's used to treat several types of cancer, specifically those with mutations in the BRCA genes (breast cancer 1 and breast cancer 2 genes) or other DNA repair genes.  These mutations make cancer cells more vulnerable to PARP inhibitors.  Specific uses include:

* **Ovarian cancer:**  Olaparib is approved for treating certain types of ovarian cancer, including recurrent ovarian cancer (cancer that has come back after treatment) and as maintenance therapy (to help prevent the cancer from returning).
* **Breast cancer:**  It's used to treat certain types of HER2-negative metastatic breast cancer (breast cancer that has spread to other parts of the body) with a BRCA mutation.
* **Pancreatic cancer:**  It can be used for certain types of advanced pancreatic cancer with a BRCA mutation or other specific DNA repair gene mutations.
* **Prostate cancer:** It is used to treat certain types of metastatic castration-resistant prostate cancer (mCRPC) with a BRCA mutation or other specific DNA repair gene mutations.


**Side Effects:** Olaparib can cause a range of side effects, some common and some less frequent but potentially serious.  These can include:

* **Common side effects:** Nausea, vomiting, diarrhea, fatigue, loss of appetite, headache, constipation, anemia (low red blood cell count).
* **Serious side effects:**  Myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) (blood cancers), low blood cell counts (neutropenia, thrombocytopenia), liver problems (hepatotoxicity), lung problems (interstitial lung disease), kidney problems, severe allergic reactions.

**It's crucial to note:** This is not an exhaustive list, and the severity and frequency of side effects can vary greatly from person to person.  Patients should immediately report any concerning side effects to their doctor.

**How it Works:** Olaparib is a PARP inhibitor. PARP (poly(ADP-ribose) polymerase) is an enzyme involved in DNA repair.  Cancer cells with BRCA gene mutations or other defects in DNA repair mechanisms rely heavily on PARP for repair. Olaparib blocks PARP, preventing the repair of damaged DNA. This leads to an accumulation of DNA damage in cancer cells, ultimately causing them to die while leaving healthy cells relatively unaffected.


**FAQs:**

* **Is Olaparib a chemotherapy drug?**  No, it's a targeted therapy, meaning it specifically targets cancer cells with certain genetic mutations, unlike chemotherapy which targets rapidly dividing cells generally.
* **How is Olaparib administered?** It's typically taken as an oral tablet.
* **How long do I need to take Olaparib?** The duration of treatment depends on the type and stage of cancer, response to the medication, and the occurrence of side effects.  This is determined by an oncologist.
* **What are the interactions with other medications?**  Olaparib can interact with other medications.  It's crucial to inform your doctor about all medications, supplements, and herbal remedies you are taking.
* **What are the long-term effects of Olaparib?** Long-term effects can include some of the serious side effects listed above, which is why close monitoring by a healthcare professional is essential.  The risk of long-term side effects varies depending on individual factors and the duration of treatment.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  They can provide personalized information based on your specific situation and medical history.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.